163 related articles for article (PubMed ID: 10229636)
21. Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.
Fang L; Knapp RJ; Horvath R; Matsunaga TO; Haaseth RC; Hruby VJ; Porreca F; Yamamura HI
J Pharmacol Exp Ther; 1994 Feb; 268(2):836-46. PubMed ID: 8113996
[TBL] [Abstract][Full Text] [Related]
22. Design of peptidomimetic delta opioid receptor antagonists using the message-address concept.
Portoghese PS; Sultana M; Takemori AE
J Med Chem; 1990 Jun; 33(6):1714-20. PubMed ID: 2160538
[TBL] [Abstract][Full Text] [Related]
23. Delta opioid antagonist activity and binding studies of regioisomeric isothiocyanate derivatives of naltrindole: evidence for delta receptor subtypes.
Portoghese PS; Sultana M; Nelson WL; Klein P; Takemori AE
J Med Chem; 1992 Oct; 35(22):4086-91. PubMed ID: 1331455
[TBL] [Abstract][Full Text] [Related]
24. 7'-Substituted amino acid conjugates of naltrindole. Hydrophilic groups as determinants of selective antagonism of delta 1 opioid receptor-mediated antinociception in mice.
Portoghese PS; Farouz-Grant F; Sultana M; Takemori AE
J Med Chem; 1995 Feb; 38(3):402-7. PubMed ID: 7853332
[TBL] [Abstract][Full Text] [Related]
25. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
Liao S; Alfaro-Lopez J; Shenderovich MD; Hosohata K; Lin J; Li X; Stropova D; Davis P; Jernigan KA; Porreca F; Yamamura HI; Hruby VJ
J Med Chem; 1998 Nov; 41(24):4767-76. PubMed ID: 9822547
[TBL] [Abstract][Full Text] [Related]
26. Opioid agonist and antagonist activities of morphindoles related to naltrindole.
Portoghese PS; Larson DL; Sultana M; Takemori AE
J Med Chem; 1992 Nov; 35(23):4325-9. PubMed ID: 1333013
[TBL] [Abstract][Full Text] [Related]
27. BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism.
Husbands SM; Neilan CL; Broadbear J; Grundt P; Breeden S; Aceto MD; Woods JH; Lewis JW; Traynor JR
Eur J Pharmacol; 2005 Feb; 509(2-3):117-25. PubMed ID: 15733546
[TBL] [Abstract][Full Text] [Related]
28. Highly selective fluorescent analogue of the potent delta-opioid receptor antagonist Dmt-Tic.
Balboni G; Salvadori S; Dal Piaz A; Bortolotti F; Argazzi R; Negri L; Lattanzi R; Bryant SD; Jinsmaa Y; Lazarus LH
J Med Chem; 2004 Dec; 47(26):6541-6. PubMed ID: 15588089
[TBL] [Abstract][Full Text] [Related]
29. Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonists.
Li T; Fujita Y; Shiotani K; Miyazaki A; Tsuda Y; Ambo A; Sasaki Y; Jinsmaa Y; Marczak E; Bryant SD; Salvadori S; Lazarus LH; Okada Y
J Med Chem; 2005 Dec; 48(25):8035-44. PubMed ID: 16335927
[TBL] [Abstract][Full Text] [Related]
30. Selective delta-opioid receptor ligands: potential PET ligands based on naltrindole.
Clayson J; Jales A; Tyacke RJ; Hudson AL; Nutt DJ; Lewis JW; Husbands SM
Bioorg Med Chem Lett; 2001 Apr; 11(7):939-43. PubMed ID: 11294396
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
[TBL] [Abstract][Full Text] [Related]
32. Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist.
Portoghese PS; Sultana M; Takemori AE
Eur J Pharmacol; 1988 Jan; 146(1):185-6. PubMed ID: 2832195
[No Abstract] [Full Text] [Related]
33. (E)- and (Z)-7-arylidenenaltrexones: synthesis and opioid receptor radioligand displacement assays.
Palmer RB; Upthagrove AL; Nelson WL
J Med Chem; 1997 Feb; 40(5):749-53. PubMed ID: 9057861
[TBL] [Abstract][Full Text] [Related]
34. Mutational evidence for a common kappa antagonist binding pocket in the wild-type kappa and mutant mu[K303E] opioid receptors.
Jones RM; Hjorth SA; Schwartz TW; Portoghese PS
J Med Chem; 1998 Dec; 41(25):4911-4. PubMed ID: 9836606
[No Abstract] [Full Text] [Related]
35. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity to μ-opioid receptor-mediated anti-nociception is determined by cross-regulation between μ- and δ-opioid receptors at supraspinal level.
Ballesta JJ; Cremades J; Rodríguez-Muñoz M; Garzón J; Faura CC
Br J Pharmacol; 2012 May; 166(1):309-26. PubMed ID: 22023056
[TBL] [Abstract][Full Text] [Related]
37. Binding, pharmacological and immunological profiles of the delta-selective opioid receptor antagonist HS 378.
Spetea M; Harris HE; Berzetei-Gurske IP; Klareskog L; Schmidhammer H
Life Sci; 2001 Aug; 69(15):1775-82. PubMed ID: 11665839
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR
Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957
[TBL] [Abstract][Full Text] [Related]
39. An immortalized myocyte cell line, HL-1, expresses a functional delta -opioid receptor.
Neilan CL; Kenyon E; Kovach MA; Bowden K; Claycomb WC; Traynor JR; Bolling SF
J Mol Cell Cardiol; 2000 Dec; 32(12):2187-93. PubMed ID: 11112994
[TBL] [Abstract][Full Text] [Related]
40. Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists.
Thomas JB; Mascarella SW; Rothman RB; Partilla JS; Xu H; McCullough KB; Dersch CM; Cantrell BE; Zimmerman DM; Carroll FI
J Med Chem; 1998 May; 41(11):1980-90. PubMed ID: 9599247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
